Aurisco Pharmaceutical Co. Ltd.SSE: 605116

(605116)"Aurisco Pharmaceutical Co., Ltd."Announcement on Conversion Results of Convertible Bonds and Share Changes

· Issued by Aurisco Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 605116 · · 3 pages · Chinese

Summary by 6ix AI

Aurisco Pharmaceutical Co. Ltd. has announced the results of its convertible bond conversions and related share changes. As of a recent date, a small number of convertible bonds have been converted into common shares, while the majority remain unconverted. There were no changes in share capital during the reporting period due to a lack of conversions.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/605116aurisco-pharmaceutical-co-ltdannouncement-on-conversion-results-of-convertible-bonds-and-share-changes

Release

Announcement on Conversion Results of Convertible Bonds and Share Changes

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Aurisco Pharmaceutical Co. Ltd. on 6ix

Story so far

Earlier from Aurisco Pharmaceutical

All Aurisco Pharmaceutical news releases